AI predicting brain cancer recurrence represents a groundbreaking advancement in the realm of pediatric oncology.A recent study conducted by Harvard researchers reveals that artificial intelligence outperforms traditional methods in anticipating relapse risk for children suffering from brain tumors, specifically pediatric gliomas.